Focus Partners Wealth
CRDF icon

Focus Partners Wealth’s Cardiff Oncology CRDF Stock Holding History

Focus Partners Wealth’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.2K Buy
+10,144
New +$16.1K ﹤0.01% 2749
2025
Q4 		– Sell
-5,185
Closed -$205K – 2695
2025
Q3 		$205K Buy
+5,185
New +$14.3K ﹤0.01% 2045

Other funds holding CRDF

LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Focus Partners Wealth's CRDF Position: Q2 2026 in Review

Focus Partners Wealth opened a new position in Cardiff Oncology (CRDF) in Q2 2026: 10,144 shares worth $13.2K. The stake represents ﹤0.01% of the portfolio and ranks #2749 among its holdings. This is a return to the name: Focus Partners Wealth previously reported a position in CRDF as recently as Q3 2025.

Focus Partners Wealth first reported a position in CRDF in Q3 2025 and has held it in 2 quarters since. The position peaked at $205K in Q3 2025. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • Focus Partners Wealth held 10,144 shares of Cardiff Oncology worth $13.2K as of Q2 2026.
  • Cardiff Oncology was a new Focus Partners Wealth position in Q2 2026.
  • Cardiff Oncology made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #2749 holding.
  • Focus Partners Wealth first reported a position in Cardiff Oncology in Q3 2025 and has held it in 2 quarters since.
  • Focus Partners Wealth's Cardiff Oncology position peaked at $205K in Q3 2025.
  • 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.